Skip to main content

Table 4 Logistic regression of poor functional outcomes according to FBG/HbA1c quartiles

From: Fasting blood glucose-to-glycated hemoglobin ratio and all-cause mortality among Chinese in-hospital patients with acute stroke: a 12-month follow-up study

Outcomes FBG/HbA1c n Events, n (%) Crude OR (95% CI) p Value Adjusted OR (95% CI)a p Value
Secondary Outcomes: after discharge
 Poor functional outcomes (mRS of 3–6) at 3 months Q1 (≤ 0.81) 214 32 (16.4) Ref   Ref  
Q2 (0.82–0.91) 212 46 (21.7) 1.42 (0.87–2.31) 0.161 1.50 (0.85–2.65) 0.159
Q3 (0.92–1.06) 210 50 (23.8) 1.64 (1.02–2.65) 0.043 1.16 (0.66–2.05) 0.601
Q4 (≥ 1.07) 210 72 (34.3) 2.67 (1.68–4.23)  < 0.001 1.33 (0.75–2.36) 0.341
 Poor functional outcomes (mRS of 3–6) at 12 months Q1 (≤ 0.81) 183 52 (28.4) Ref   Ref  
Q2 (0.82–0.91) 189 49 (25.9) 0.88 (0.56–1.39) 0.589 1.16 (0.68–1.99) 0.582
Q3 (0.92–1.06) 190 57 (30.0) 1.08 (0.69–1.69) 0.737 0.94 (0.55–1.59) 0.803
Q4 (≥ 1.07) 181 83 (45.9) 2.13 (1.38–3.29) 0.001 1.68 (0.97–2.90) 0.062
  1. Quartiles of FBG/HbA1c ratio, Q1 ≤ 0.81, 0.82 ≤ Q2 < 0.91, 0.92 ≤ Q3 < 1.06, Q4 ≥ 1.07
  2. FBG Fasting blood glucose, HbA1c Glycated hemoglobin
  3. aLogistic regression is adjusted for sex, age, NIHSS, type of stroke, atrial fibrillation, hypertension, diabetes, coronary heart disease, hyperlipemia, previous stroke, history of smoking, history of drinking, and infectious complications